AMCo Amdipharm Mercury Pharmaceuticals

About us

Amdipharm Mercury (AMCo) is a rapidly growing international pharmaceutical company, committed to bringing its portfolio of niche medicines to patients in more than 100 countries. AMCo is the result of the merger in 2013 of Amdipharm and the Mercury Pharma Group.

Read more

Latest News

  • 19/03/2015: AMCo has launched Pevanti®

    AMCo has launched Pevanti® – a new branded range of prednisolone tablets for the treatment of a wide range of inflammatory and auto-immune conditions.

More news

More news


Amdipharm Mercury (AMCo) has a broad product portfolio with sales in numerous territories. For more information please visit our Products page.

Consultant anaesthetists share their knowledge and experience of Prilotekal. To find out more click here

Our Products